NEUROPACE INC. - COMMON STOCK

NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

10 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors

09 Jan 2023 15:03:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference

21 Dec 2022 15:03:00 By Nasdaq GlobeNewswire

NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update

08 Nov 2022 15:03:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference

04 Nov 2022 15:03:00 By Nasdaq GlobeNewswire

NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022

25 Oct 2022 15:03:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the Morgan Stanley 20th Annual Global Healthcare Conference      

23 Aug 2022 15:06:00 By Nasdaq GlobeNewswire

NeuroPace Reports Second Quarter 2022 Financial Results and Provides a Business Update

11 Aug 2022 15:02:00 By Nasdaq GlobeNewswire

NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments for Neurosurgery

11 Aug 2022 15:02:00 By Nasdaq GlobeNewswire

NeuroPace to Report Second Quarter 2022 Financial Results on August 11, 2022

21 Jul 2022 15:03:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the 2022 RBC Capital Markets Global Healthcare Conference

13 May 2022 07:00:00 By Nasdaq GlobeNewswire

NeuroPace Reports First Quarter 2022 Financial Results

12 May 2022 15:03:00 By Nasdaq GlobeNewswire

NeuroPace to Report First Quarter 2022 Financial Results on May 12, 2022

21 Apr 2022 15:03:00 By Nasdaq GlobeNewswire

NeuroPace Reports Fourth Quarter & Full Year 2021 Financial Results

10 Mar 2022 15:02:00 By Nasdaq GlobeNewswire

NeuroPace to Report Fourth Quarter and Full Year 2021 Financial Results and Present at the 11th Annual SVB Leerink Global Healthcare Conference 

27 Jan 2022 15:03:00 By Nasdaq GlobeNewswire

NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue

11 Jan 2022 15:03:00 By Nasdaq GlobeNewswire

NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference

16 Dec 2021 06:00:00 By Nasdaq GlobeNewswire

NeuroPace Reports Third Quarter 2021 Financial Results

10 Nov 2021 15:03:00 By Nasdaq GlobeNewswire

NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy

10 Nov 2021 15:02:00 By Nasdaq GlobeNewswire

NeuroPace to Report Third Quarter 2021 Financial Results on November 10, 2021

20 Oct 2021 15:05:00 By Nasdaq GlobeNewswire